Drug Shortage Report for TARO-TESTOSTERONE GEL
Report ID | 83914 |
Drug Identification Number | 02463806 |
Brand name | TARO-TESTOSTERONE GEL |
Common or Proper name | TARO-TESTOSTERONE GEL |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE |
Strength(s) | 1% |
Dosage form(s) | GEL |
Route of administration | TRANSDERMAL |
Packaging size | 5 g |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-05-06 |
Estimated end date | 2019-07-19 |
Actual end date | 2019-07-16 |
Shortage status | Resolved |
Updated date | 2019-07-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2019-07-19 | French | Compare |
v11 | 2019-07-19 | English | Compare |
v10 | 2019-07-05 | French | Compare |
v9 | 2019-07-05 | English | Compare |
v8 | 2019-06-24 | French | Compare |
v7 | 2019-06-24 | English | Compare |
v6 | 2019-06-17 | French | Compare |
v5 | 2019-06-17 | English | Compare |
v4 | 2019-05-28 | French | Compare |
v3 | 2019-05-28 | English | Compare |
v2 | 2019-05-13 | French | Compare |
v1 | 2019-05-13 | English | Compare |
Showing 1 to 12 of 12